2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2020
Tóm tắt
The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee (https://doi.org/10.2337/dc20-SPPC), a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc20-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Từ khóa
Tài liệu tham khảo
American Diabetes Association, 2014, Diagnosis and classification of diabetes mellitus, Diabetes Care, S81
Dabelea, 2014, SEARCH for Diabetes in Youth Study Group. Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for Diabetes in Youth Study, Pediatrics, e938
Humphreys, 2019, Individual and diabetes presentation characteristics associated with partial remission status in children and adults evaluated up to 12 months following diagnosis of type 1 diabetes: an ADDRESS-2 (After Diagnosis Diabetes Research Support System-2) study analysis, Diabetes Res Clin Pract, 155, 107789, 10.1016/j.diabres.2019.107789
Thomas, 2019, Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes, Diabetologia, 62, 1167, 10.1007/s00125-019-4863-8
Hope, 2016, Practical classification guidelines for diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis, Br J Gen Pract, 66, e315, 10.3399/bjgp16X684961
Zhong, 2018, Trends in hospital admission for diabetic ketoacidosis in adults with type 1 and type 2 diabetes in England, 1998–2013: a retrospective cohort study, Diabetes Care, 41, 1870, 10.2337/dc17-1583
Newton, 2004, Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences, Arch Intern Med, 164, 1925, 10.1001/archinte.164.17.1925
Skyler, 2017, Differentiation of diabetes by pathophysiology, natural history, and prognosis, Diabetes, 66, 241, 10.2337/db16-0806
Insel, 2015, Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association, Diabetes Care, 38, 1964, 10.2337/dc15-1419
Schwartz, 2016, The time is right for a new classification system for diabetes: rationale and implications of the β-cell-centric classification schema, Diabetes Care, 39, 179, 10.2337/dc15-1585
International Expert Committee, 2009, International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes, Diabetes Care, 32, 1327, 10.2337/dc09-9033
Knowler, 2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 346, 393, 10.1056/NEJMoa012512
Tuomilehto, 2001, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N Engl J Med, 344, 1343, 10.1056/NEJM200105033441801
Meijnikman, 2017, Not performing an OGTT results in significant underdiagnosis of (pre)diabetes in a high risk adult Caucasian population, Int J Obes, 41, 1615, 10.1038/ijo.2017.165
Cowie, 2010, Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988–2006, Diabetes Care, 33, 562, 10.2337/dc09-1524
Eckhardt, 2012, Glycated hemoglobin A1c as screening for diabetes mellitus in HIV-infected individuals, AIDS Patient Care STDS, 26, 197, 10.1089/apc.2011.0379
Arslanian, 2018, Evaluation and management of youth-onset type 2 diabetes: a position statement by the American Diabetes Association, Diabetes Care, 41, 2648, 10.2337/dci18-0052
Lacy, 2017, Association of sickle cell trait with hemoglobin A1c in African Americans, 10.1001/jama.2016.21035
Wheeler, 2017, Impact of common genetic determinants of hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: a transethnic genome-wide meta-analysis, PLoS Med, 14, e1002383, 10.1371/journal.pmed.1002383
Ziemer, 2010, Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies, Ann Intern Med, 152, 770, 10.7326/0003-4819-152-12-201006150-00004
Kumar, 2010, Utility of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-based study, J Clin Endocrinol Metab, 95, 2832, 10.1210/jc.2009-2433
Herman, 2016, Are there clinical implications of racial differences in HbA1c? Yes, to not consider can do great harm!, Diabetes Care, 39, 1458, 10.2337/dc15-2686
Herman, 2007, Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program, Diabetes Care, 30, 2453, 10.2337/dc06-2003
Bergenstal, 2017, Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels, Ann Intern Med, 167, 95, 10.7326/M16-2596
Selvin, 2011, Racial differences in glycemic markers: a cross-sectional analysis of community-based data, Ann Intern Med, 154, 303, 10.7326/0003-4819-154-5-201103010-00004
Herman, 2009, Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes, J Clin Endocrinol Metab, 94, 1689, 10.1210/jc.2008-1940
Selvin, 2013, No racial differences in the association of glycated hemoglobin with kidney disease and cardiovascular outcomes, Diabetes Care, 36, 2995, 10.2337/dc12-2715
Selvin, 2016, Are there clinical implications of racial differences in HbA1c? A difference, to be a difference, must make a difference, Diabetes Care, 39, 1462, 10.2337/dc16-0042
Paterson, 2017, HbA1c for type 2 diabetes diagnosis in Africans and African Americans: personalized medicine NOW!, PLoS Med, 14, e1002384, 10.1371/journal.pmed.1002384
Cappellini, 2008, Glucose-6-phosphate dehydrogenase deficiency, Lancet, 371, 64, 10.1016/S0140-6736(08)60073-2
Picón, 2012, Hemoglobin A1c versus oral glucose tolerance test in postpartum diabetes screening, Diabetes Care, 35, 1648, 10.2337/dc11-2111
Göbl, 2014, Is early postpartum HbA1c an appropriate risk predictor after pregnancy with gestational diabetes mellitus?, Acta Diabetol, 51, 715, 10.1007/s00592-014-0574-2
Megia, 2012, The usefulness of HbA1c in postpartum reclassification of gestational diabetes, BJOG, 119, 891, 10.1111/j.1471-0528.2012.03325.x
Welsh, 2016, Role of glycated proteins in the diagnosis and management of diabetes: research gaps and future directions, Diabetes Care, 39, 1299, 10.2337/dc15-2727
Kim, 2010, Association between iron deficiency and A1C Levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999–2006, Diabetes Care, 33, 780, 10.2337/dc09-0836
Selvin, 2018, Prognostic implications of single-sample confirmatory testing for undiagnosed diabetes: a prospective cohort study, Ann Intern Med, 169, 156, 10.7326/M18-0091
Mishra, 2018, A global perspective of latent autoimmune diabetes in adults, Trends Endocrinol Metab, 29, 638, 10.1016/j.tem.2018.07.001
Buzzetti, 2017, Adult-onset autoimmune diabetes: current knowledge and implications for management, Nat Rev Endocrinol, 13, 674, 10.1038/nrendo.2017.99
Dabelea, 2014, Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009, JAMA, 311, 1778, 10.1001/jama.2014.3201
Ziegler, 2013, Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children, JAMA, 309, 2473, 10.1001/jama.2013.6285
Sosenko, 2013, The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients, Diabetes Care, 36, 2615, 10.2337/dc13-0425
Steck, 2015, Predictors of progression from the appearance of islet autoantibodies to early childhood diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY), Diabetes Care, 38, 808, 10.2337/dc14-2426
Orban, 2009, Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1, Diabetes Care, 32, 2269, 10.2337/dc09-0934
Jacobsen, 2019, Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children, Pediatr Diabetes, 20, 263, 10.1111/pedi.12812
American Diabetes Association, 2011, Diagnosis and classification of diabetes mellitus, Diabetes Care, 34, S62, 10.2337/dc11-S062
Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 1997, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care, 20, 1183, 10.2337/diacare.20.7.1183
Zhang, 2010, A1C level and future risk of diabetes: a systematic review, Diabetes Care, 33, 1665, 10.2337/dc09-1939
Selvin, 2010, Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults, N Engl J Med, 362, 800, 10.1056/NEJMoa0908359
Ackermann, 2011, Identifying adults at high risk for diabetes and cardiovascular disease using hemoglobin A1c National Health and Nutrition Examination Survey 2005-2006, Am J Prev Med, 40, 11, 10.1016/j.amepre.2010.09.022
Diabetes Prevention Program Research Group, 2015, HbA1c as a predictor of diabetes and as an outcome in the diabetes prevention program: a randomized clinical trial, Diabetes Care, 38, 51, 10.2337/dc14-0886
Umpierrez, 2016, Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia, Nat Rev Endocrinol, 12, 222, 10.1038/nrendo.2016.15
Fadini, 2017, SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System, Diabetologia, 60, 1385, 10.1007/s00125-017-4301-8
Griffin, 2011, Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial, Lancet, 378, 156, 10.1016/S0140-6736(11)60698-3
Genuth, 2003, Follow-up report on the diagnosis of diabetes mellitus, Diabetes Care, 26, 3160, 10.2337/diacare.26.11.3160
Peterson, 2015, Preventable health and cost burden of adverse birth outcomes associated with pregestational diabetes in the United States, Am J Obstet Gynecol, 212, 74.e1, 10.1016/j.ajog.2014.09.009
Herman, 2015, Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe), Diabetes Care, 38, 1449, 10.2337/dc14-2459
Kahn, 2010, Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis, Lancet, 375, 1365, 10.1016/S0140-6736(09)62162-0
Araneta, 2014, Optimum BMI cut-points to screen Asian Americans for type 2 diabetes: The UCSD Filipino Health Study and the North Kohala Study [Abstract], Diabetes, A20
Hsu, 2015, BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening, Diabetes Care, 38, 150, 10.2337/dc14-2391
WHO Expert Consultation, 2004, Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies, Lancet, 363, 157, 10.1016/S0140-6736(03)15268-3
Menke, 2015, Prevalence of and trends in diabetes among adults in the United States, 1988-2012, JAMA, 314, 1021, 10.1001/jama.2015.10029
Centers for Disease Control and Prevention . National diabetes statistics report: estimates of diabetes and its burden in the United States, 2017. Accessed 31 October 2019. Available from https://www.cdc.gov/diabetes/data/statistics/statistics-report.html
Chiu, 2011, Deriving ethnic-specific BMI cutoff points for assessing diabetes risk, Diabetes Care, 34, 1741, 10.2337/dc10-2300
Erickson, 2012, New-onset treatment-dependent diabetes mellitus and hyperlipidemia associated with atypical antipsychotic use in older adults without schizophrenia or bipolar disorder, J Am Geriatr Soc, 60, 474, 10.1111/j.1532-5415.2011.03842.x
Johnson, 2005, The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of age, Diabetes Care, 28, 307, 10.2337/diacare.28.2.307
Tabaei, 2003, Community-based screening for diabetes in Michigan, Diabetes Care, 26, 668, 10.2337/diacare.26.3.668
Lalla, 2011, Identification of unrecognized diabetes and pre-diabetes in a dental setting, J Dent Res, 90, 855, 10.1177/0022034511407069
Lalla, 2013, Dental findings and identification of undiagnosed hyperglycemia, J Dent Res, 92, 888, 10.1177/0022034513502791
Herman, 2015, Screening for prediabetes and type 2 diabetes in dental offices, J Public Health Dent, 75, 175, 10.1111/jphd.12082
Buse, 2013, Diabetes screening with hemoglobin A1c versus fasting plasma glucose in a multiethnic middle-school cohort, Diabetes Care, 36, 429, 10.2337/dc12-0295
Kapadia, 2012, Hemoglobin A1c measurement for the diagnosis of type 2 diabetes in children, Int J Pediatr Endocrinol, 2012, 31, 10.1186/1687-9856-2012-31
Kester, 2012, Using hemoglobin A1c for prediabetes and diabetes diagnosis in adolescents: can adult recommendations be upheld for pediatric use?, J Adolesc Health, 50, 321, 10.1016/j.jadohealth.2012.02.009
Wu, 2013, Cost-effectiveness of screening strategies for identifying pediatric diabetes mellitus and dysglycemia, JAMA Pediatr, 167, 32, 10.1001/jamapediatrics.2013.419
Moran, 2018, ISPAD Clinical Practice Consensus Guidelines 2018: management of cystic fibrosis-related diabetes in children and adolescents, Pediatr Diabetes, 19, 64, 10.1111/pedi.12732
Gilmour, 2019, Cystic fibrosis-related diabetes screening in adults: a gap analysis and evaluation of accuracy of glycated hemoglobin levels, Can J Diabetes, 43, 13, 10.1016/j.jcjd.2018.04.008
Gilmour, 2019, Response to the Letter to the Editor from Dr. Boudreau et al, “Validation of a Stepwise Approach Using Glycated Hemoglobin Levels to Reduce the Number of Required Oral Glucose Tolerance Tests to Screen for Cystic Fibrosis-Related Diabetes in Adults”, Can J Diabetes, 43, 163, 10.1016/j.jcjd.2019.02.002
Mainguy, 2017, Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?, J Pediatr Endocrinol Metab, 30, 27, 10.1515/jpem-2016-0184
Ode, 2013, New insights into cystic fibrosis-related diabetes in children, Lancet Diabetes Endocrinol, 1, 52, 10.1016/S2213-8587(13)70015-9
Moran, 2009, Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality, Diabetes Care, 32, 1626, 10.2337/dc09-0586
Onady, 2016, Insulin and oral agents for managing cystic fibrosis-related diabetes, Cochrane Database Syst Rev, 4, CD004730
Moran, 2010, Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society, Diabetes Care, 33, 2697, 10.2337/dc10-1768
Moran, 2014, ISPAD Clinical Practice Consensus Guidelines 2014. Management of cystic fibrosis-related diabetes in children and adolescents, Pediatr Diabetes, 15, 65, 10.1111/pedi.12178
Shivaswamy, 2016, Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes, Endocr Rev, 37, 37, 10.1210/er.2015-1084
Sharif, 2014, Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions, Am J Transplant, 14, 1992, 10.1111/ajt.12850
Hecking, 2013, Novel views on new-onset diabetes after transplantation: development, prevention and treatment, Nephrol Dial Transplant, 28, 550, 10.1093/ndt/gfs583
Ramirez, 2014, The association between glycemic control and clinical outcomes after kidney transplantation, Endocr Pract, 20, 894, 10.4158/EP13463.OR
Thomas, 2000, Early peri-operative hyperglycaemia and renal allograft rejection in patients without diabetes, BMC Nephrol, 1, 1, 10.1186/1471-2369-1-1
Chakkera, 2009, Hyperglycemia during the immediate period after kidney transplantation, Clin J Am Soc Nephrol, 4, 853, 10.2215/CJN.05471008
Wallia, 2016, Diabetes care after transplant: definitions, risk factors, and clinical management, Med Clin North Am, 100, 535, 10.1016/j.mcna.2016.01.005
Sharif, 2006, The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: an underdiagnosed phenomenon, Transplantation, 82, 1667, 10.1097/01.tp.0000250924.99855.42
Hecking, 2013, Glucose metabolism after renal transplantation, Diabetes Care, 36, 2763, 10.2337/dc12-2441
Galindo, 2016, Hyperglycemia management in patients with posttransplantation diabetes, Endocr Pract, 22, 454, 10.4158/EP151039.RA
Jenssen, 2015, Emerging treatments for post-transplantation diabetes mellitus, Nat Rev Nephrol, 11, 465, 10.1038/nrneph.2015.59
Thomas, 2001, Early peri-operative glycaemic control and allograft rejection in patients with diabetes mellitus: a pilot study, Transplantation, 72, 1321, 10.1097/00007890-200110150-00024
Kurian, 2008, Effectiveness and long-term safety of thiazolidinediones and metformin in renal transplant recipients, Endocr Pract, 14, 979, 10.4158/EP.14.8.979
Budde, 2003, The pharmacokinetics of pioglitazone in patients with impaired renal function, Br J Clin Pharmacol, 55, 368, 10.1046/j.1365-2125.2003.01785.x
Luther, 2004, Pioglitazone in the management of diabetes mellitus after transplantation, Am J Transplant, 4, 2135, 10.1111/j.1600-6143.2004.00613.x
Strøm Halden, 2014, Short-term efficacy and safety of sitagliptin treatment in long-term stable renal recipients with new-onset diabetes after transplantation, Nephrol Dial Transplant, 29, 926, 10.1093/ndt/gft536
Lane, 2011, Sitagliptin therapy in kidney transplant recipients with new-onset diabetes after transplantation, Transplantation, 92, e56, 10.1097/TP.0b013e3182347ea4
Carmody
De Franco, 2015, The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study, Lancet, 386, 957, 10.1016/S0140-6736(15)60098-8
Shields, 2010, Maturity-onset diabetes of the young (MODY): how many cases are we missing?, Diabetologia, 53, 2504, 10.1007/s00125-010-1799-4
Awa, 2011, Reclassification of diabetes type in pediatric patients initially classified as type 2 diabetes mellitus: 15 years follow-up using routine data from the German/Austrian DPV database, Diabetes Res Clin Pract, 94, 463, 10.1016/j.diabres.2011.09.011
Shepherd, 2016, Systematic population screening, using biomarkers and genetic testing, identifies 2.5% of the U.K. pediatric diabetes population with monogenic diabetes, Diabetes Care, 39, 1879, 10.2337/dc16-0645
SEARCH Study Group, 2004, SEARCH for Diabetes in Youth: a multicenter study of the prevalence, incidence and classification of diabetes mellitus in youth, Control Clin Trials, 25, 458, 10.1016/j.cct.2004.08.002
Pihoker, 2013, Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth, J Clin Endocrinol Metab, 98, 4055, 10.1210/jc.2013-1279
Draznin B (Ed.). Atypical Diabetes: Pathophysiology, Clinical Presentations, and Treatment Options. Arlington, American Diabetes Association, 2018
DiabetesGenes . MODY Probability Calculator. Accessed 26 September 2019. Available from https://www.diabetesgenes.org/mody-probability-calculator/
Urbanová, 2014, Positivity for islet cell autoantibodies in patients with monogenic diabetes is associated with later diabetes onset and higher HbA1c level, Diabet Med, 31, 466, 10.1111/dme.12314
Naylor, 2014, Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications, Diabetes Care, 37, 202, 10.2337/dc13-0410
Shields, 2017, Population-based assessment of a biomarker-based screening pathway to aid diagnosis of monogenic diabetes in young-onset patients, Diabetes Care, 40, 1017, 10.2337/dc17-0224
Hattersley, 2009, The diagnosis and management of monogenic diabetes in children and adolescents, Pediatr Diabetes, 10, 33, 10.1111/j.1399-5448.2009.00571.x
Rubio-Cabezas, 2014, ISPAD Clinical Practice Consensus Guidelines 2014. The diagnosis and management of monogenic diabetes in children and adolescents, Pediatr Diabetes, 15, 47, 10.1111/pedi.12192
Greeley, 2011, Neonatal diabetes: an expanding list of genes allows for improved diagnosis and treatment, Curr Diab Rep, 11, 519, 10.1007/s11892-011-0234-7
Le Bodic, 1996, The hereditary pancreatitis gene maps to long arm of chromosome 7, Hum Mol Genet, 5, 549, 10.1093/hmg/5.4.549
Hardt, 2008, Is pancreatic diabetes (type 3c diabetes) underdiagnosed and misdiagnosed?, Diabetes Care, 31, S165, 10.2337/dc08-s244
Woodmansey, 2017, Incidence, demographics, and clinical characteristics of diabetes of the exocrine pancreas (type 3c): a retrospective cohort study, Diabetes Care, 40, 1486, 10.2337/dc17-0542
Duggan, 2017, The nutritional management of type 3c (pancreatogenic) diabetes in chronic pancreatitis, Eur J Clin Nutr, 71, 3, 10.1038/ejcn.2016.127
Makuc, 2016, Management of pancreatogenic diabetes: challenges and solutions, Diabetes Metab Syndr Obes, 9, 311, 10.2147/DMSO.S99701
Andersen, 2017, Diabetes, pancreatogenic diabetes, and pancreatic cancer, Diabetes, 66, 1103, 10.2337/db16-1477
Bellin, 2015, Total pancreatectomy with islet autotransplantation: summary of an NIDDK workshop, Ann Surg, 261, 21, 10.1097/SLA.0000000000001059
Anazawa, 2018, Current state and future evolution of pancreatic islet transplantation, Ann Gastroenterol Surg, 3, 34, 10.1002/ags3.12214
Quartuccio, 2017, Glycemic predictors of insulin independence after total pancreatectomy with islet autotransplantation, J Clin Endocrinol Metab, 102, 801, 10.1210/jc.2016-2952
Huvinen, 2018, Effects of a lifestyle intervention during pregnancy and first postpartum year: findings from the RADIEL study, J Clin Endocrinol Metab, 103, 1669, 10.1210/jc.2017-02477
Rosenn, 1994, Glycemic thresholds for spontaneous abortion and congenital malformations in insulin-dependent diabetes mellitus, Obstet Gynecol, 84, 515
Schaefer, 1997, Congenital malformations in offspring of women with hyperglycemia first detected during pregnancy, Am J Obstet Gynecol, 177, 1165, 10.1016/S0002-9378(97)70035-8
Poltavskiy, 2016, Comparison of screening scores for diabetes and prediabetes, Diabetes Res Clin Pract, 118, 146, 10.1016/j.diabres.2016.06.022
Feig, 2014, Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996-2010, Diabetes Care, 37, 1590, 10.2337/dc13-2717
Peng, 2017, Trends and racial and ethnic disparities in the prevalence of pregestational type 1 and type 2 diabetes in Northern California: 1996-2014, Am J Obstet Gynecol, 216, 177.e1, 10.1016/j.ajog.2016.10.007
Jovanovič, 2015, Trends in the incidence of diabetes, its clinical sequelae, and associated costs in pregnancy, Diabetes Metab Res Rev, 31, 707, 10.1002/dmrr.2656
Mission, 2017, Early pregnancy diabetes screening and diagnosis: prevalence, rates of abnormal test results, and associated factors, Obstet Gynecol, 130, 1136, 10.1097/AOG.0000000000002277
McIntyre, 2016, Issues with the diagnosis and classification of hyperglycemia in early pregnancy, Diabetes Care, 39, 53, 10.2337/dc15-1887
Noctor, 2016, Abnormal glucose tolerance post-gestational diabetes mellitus as defined by the International Association of Diabetes and Pregnancy Study Groups criteria, Eur J Endocrinol, 175, 287, 10.1530/EJE-15-1260
Kim, 2002, Gestational diabetes and the incidence of type 2 diabetes: a systematic review, Diabetes Care, 25, 1862, 10.2337/diacare.25.10.1862
Ratner, 2008, Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions, J Clin Endocrinol Metab, 93, 4774, 10.1210/jc.2008-0772
Aroda, 2015, The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up, J Clin Endocrinol Metab, 100, 1646, 10.1210/jc.2014-3761
Wang, 2017, A randomized clinical trial of exercise during pregnancy to prevent gestational diabetes mellitus and improve pregnancy outcome in overweight and obese pregnant women, Am J Obstet Gynecol, 216, 340, 10.1016/j.ajog.2017.01.037
Metzger, 2008, Hyperglycemia and adverse pregnancy outcomes, N Engl J Med, 358, 1991, 10.1056/NEJMoa0707943
O’Sullivan, 1964, Criteria for the oral glucose tolerance test in pregnancy, Diabetes, 13, 278
Sacks, 2012, Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study, Diabetes Care, 35, 526, 10.2337/dc11-1641
Brown, 2017, Application of one-step IADPSG versus two-step diagnostic criteria for gestational diabetes in the real world: impact on Health Services, clinical care, and outcomes, Curr Diab Rep, 85
Lowe, 2018, Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity, JAMA, 320, 1005, 10.1001/jama.2018.11628
Landon, 2009, A multicenter, randomized trial of treatment for mild gestational diabetes, N Engl J Med, 361, 1339, 10.1056/NEJMoa0902430
Crowther, 2005, Effect of treatment of gestational diabetes mellitus on pregnancy outcomes, N Engl J Med, 352, 2477, 10.1056/NEJMoa042973
Tam, 2017, In utero exposure to maternal hyperglycemia increases childhood cardiometabolic risk in offspring, Diabetes Care, 40, 679, 10.2337/dc16-2397
Landon, 2015, Mild gestational diabetes mellitus and long-term child health, Diabetes Care, 38, 445, 10.2337/dc14-2159
Vandorsten, 2013, NIH consensus development conference: diagnosing gestational diabetes mellitus, NIH Consens State Sci Statements, 29, 1
Committee on Practice Bulletins—Obstetrics, 2018, Practice Bulletin No. 190: gestational diabetes mellitus, Obstet Gynecol, 131, e49, 10.1097/AOG.0000000000002501
Donovan, 2013, Screening tests for gestational diabetes: a systematic review for the U.S. Preventive Services Task Force, Ann Intern Med, 159, 115, 10.7326/0003-4819-159-2-201307160-00657
Khalafallah, 2016, Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus, BMJ Open, 6, e011059, 10.1136/bmjopen-2016-011059
Horvath, 2010, Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis, BMJ, 10.1136/bmj.c1395
Carpenter, 1982, Criteria for screening tests for gestational diabetes, Am J Obstet Gynecol, 144, 768, 10.1016/0002-9378(82)90349-0
National Diabetes Data Group, 1979, Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance, Diabetes, 28, 1039, 10.2337/diab.28.12.1039
Harper, 2016, Carpenter-Coustan compared with National Diabetes Data Group criteria for diagnosing gestational diabetes, Obstet Gynecol, 127, 893, 10.1097/AOG.0000000000001383
Werner, 2012, Screening for gestational diabetes mellitus: are the criteria proposed by the International Association of the Diabetes and Pregnancy Study Groups cost-effective?, Diabetes Care, 35, 529, 10.2337/dc11-1643
Duran, 2014, Introduction of IADPSG criteria for the screening and diagnosis of gestational diabetes mellitus results in improved pregnancy outcomes at a lower cost in a large cohort of pregnant women: the St. Carlos Gestational Diabetes Study, Diabetes Care, 37, 2442, 10.2337/dc14-0179
Wei, 2014, International Association of Diabetes and Pregnancy Study Group criteria is suitable for gestational diabetes mellitus diagnosis: further evidence from China, Chin Med J (Engl), 127, 3553, 10.3760/cma.j.issn.0366-6999.20140898
Feldman, 2016, Gestational diabetes screening: the International Association of the Diabetes and Pregnancy Study Groups compared with Carpenter-Coustan screening, Obstet Gynecol, 127, 10, 10.1097/AOG.0000000000001132
Ethridge, 2014, Perinatal outcomes associated with the diagnosis of gestational diabetes made by the international association of the diabetes and pregnancy study groups criteria, Obstet Gynecol, 124, 571, 10.1097/AOG.0000000000000412
Mayo, 2015, The impact of adoption of the international association of diabetes in pregnancy study group criteria for the screening and diagnosis of gestational diabetes, Am J Obstet Gynecol, 212, 224.e1, 10.1016/j.ajog.2014.08.027